NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/CNS Tumors — Gliomas
    CNS Tumors — Gliomas
    medium
    microscope Pathology

    A 52-year-old man presents with progressive headaches, focal seizures, and imaging reveals a contrast-enhancing mass in the frontal lobe with significant peritumoral edema. Biopsy confirms WHO Grade IV glioblastoma multiforme. After maximal safe surgical resection, what is the drug of choice for adjuvant chemotherapy?

    A. Temozolomide
    B. Methotrexate
    C. Cisplatin
    D. Vincristine

    Explanation

    ## Standard Adjuvant Chemotherapy for Glioblastoma **Key Point:** Temozolomide is the gold-standard alkylating agent for WHO Grade IV glioblastoma, used as both concurrent and adjuvant therapy following surgery and radiotherapy. **High-Yield:** The landmark Stupp protocol (2005) established concurrent temozolomide during radiotherapy followed by 6 cycles of adjuvant temozolomide as the standard of care for newly diagnosed glioblastoma. This regimen significantly improves overall survival compared to radiotherapy alone. ### Why Temozolomide? | Feature | Temozolomide | Cisplatin | Methotrexate | Vincristine | |---------|--------------|-----------|--------------|-------------| | **BBB penetration** | Excellent (lipophilic) | Poor | Poor | Poor | | **Oral bioavailability** | Yes | No (IV only) | No (IV/IT) | No (IV only) | | **Standard glioblastoma use** | Yes (Stupp protocol) | No | No | No (used in pediatric medulloblastoma) | | **Myelosuppression** | Moderate | Severe | Moderate | Severe | | **Renal toxicity** | Minimal | Significant | Minimal | Minimal | **Clinical Pearl:** Temozolomide undergoes spontaneous hydrolysis at physiologic pH to form the active metabolite MTIC (methyltriazenimidazole carboxamide), which methylates DNA at the O-6 position of guanine, leading to apoptosis. Its lipophilic nature allows superior blood–brain barrier (BBB) penetration compared to hydrophilic agents. **Mnemonic:** **STUPP** = Surgery, Temozolomide (concurrent), Radiotherapy, Post-operative temozolomide (adjuvant) — the standard protocol for glioblastoma. ### Dosing in Glioblastoma 1. **Concurrent phase:** 75 mg/m² daily during radiotherapy (6 weeks) 2. **Adjuvant phase:** 150–200 mg/m² daily for 5 days, repeated every 28 days for up to 6 cycles **Warning:** Patients with methylated MGMT (O-6-methylguanine-DNA methyltransferase) promoter show better response to temozolomide and improved prognosis — MGMT status is now a key prognostic and predictive marker in glioblastoma. [cite:Robbins 10e Ch 28]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions